Over the last two or three months, we have been observing an accelerating pace of critical news stores focusing the business practices of both the PBM industry and Drug Manufacturers. Now, Rueters is reporting that twenty states are suing Mylan and Teva over drug pricing. Knowing what I do about lawsuits, it will be quite some time before this is resolved, but I would not be surprised if the PBM industry and drug wholesalers are soon included in this type of action. In many ways, the story of greed and corruption in the drug industry is starting to resesmble a line of dominoes, each one falling on the next.
To read the Rueters story, point your browser of choice to U.S. states sue Mylan, Teva, others for fixing drug prices.